Autolus Therapeutics (AUTL) Misses Q3 EPS by 1c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Iridex Corp (IRIX) Misses Q2 EPS by 5c
• Taylor Devices (TAYD) Misses Q4 EPS by 31c